These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1431 related articles for article (PubMed ID: 32514151)

  • 1. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer.
    Fong W; Li Q; Yu J
    Oncogene; 2020 Jun; 39(26):4925-4943. PubMed ID: 32514151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
    Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
    Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes.
    Perillo F; Amoroso C; Strati F; Giuffrè MR; Díaz-Basabe A; Lattanzi G; Facciotti F
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intervention on gut microbiota may change the strategy for management of colorectal cancer.
    Taghinezhad-S S; Mohseni AH; Fu X
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1508-1517. PubMed ID: 33295040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of diet and gut microbiota on colorectal cancer immunomodulation.
    De Almeida CV; de Camargo MR; Russo E; Amedei A
    World J Gastroenterol; 2019 Jan; 25(2):151-162. PubMed ID: 30670906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota modulation: a tool for the management of colorectal cancer.
    Wang Y; Li H
    J Transl Med; 2022 Apr; 20(1):178. PubMed ID: 35449107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutraceuticals in colorectal cancer: A mechanistic approach.
    Rossi M; Mirbagheri SEYEDS; Keshavarzian A; Bishehsari F
    Eur J Pharmacol; 2018 Aug; 833():396-402. PubMed ID: 29935172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of the Gut Microbiome in Colorectal Cancer: Where Are We? Where Are We Going?
    Wieczorska K; Stolarek M; Stec R
    Clin Colorectal Cancer; 2020 Mar; 19(1):5-12. PubMed ID: 31678050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of dysbiotic human gut microbiome for homeostasis.
    Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
    Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Microbiome and Antibiotics in Autoimmune Diseases.
    Vangoitsenhoven R; Cresci GAM
    Nutr Clin Pract; 2020 Jun; 35(3):406-416. PubMed ID: 32319703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbe-based management for colorectal cancer.
    Gao ZY; Cui Z; Yan YQ; Ning LJ; Wang ZH; Hong J
    Chin Med J (Engl); 2021 Dec; 134(24):2922-2930. PubMed ID: 34855639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial Interactions and Interventions in Colorectal Cancer.
    Van Raay T; Allen-Vercoe E
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28643625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the gut microbiota in tumor, immunity, and immunotherapy.
    Xie Y; Liu F
    Front Immunol; 2024; 15():1410928. PubMed ID: 38903520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics, prebiotics and colorectal cancer prevention.
    Ambalam P; Raman M; Purama RK; Doble M
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):119-31. PubMed ID: 27048903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota in common elderly diseases affecting activities of daily living.
    Shimizu Y
    World J Gastroenterol; 2018 Nov; 24(42):4750-4758. PubMed ID: 30479462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view.
    Chen HT; Huang HL; Li YQ; Xu HM; Zhou YJ
    World J Gastroenterol; 2020 Apr; 26(16):1901-1911. PubMed ID: 32390701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucins, gut microbiota, and postbiotics role in colorectal cancer.
    Pothuraju R; Chaudhary S; Rachagani S; Kaur S; Roy HK; Bouvet M; Batra SK
    Gut Microbes; 2021; 13(1):1974795. PubMed ID: 34586012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics and postbiotics in colorectal cancer: Prevention and complementary therapy.
    Kvakova M; Kamlarova A; Stofilova J; Benetinova V; Bertkova I
    World J Gastroenterol; 2022 Jul; 28(27):3370-3382. PubMed ID: 36158273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care.
    Ciernikova S; Sevcikova A; Drgona L; Mego M
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188990. PubMed ID: 37742728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.